Neurizon Therapeutics (FRA:ECQ0) YoY Rev. per Sh. Growth : 0.00% (As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Neurizon Therapeutics YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Neurizon Therapeutics's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2024 was 0.00%.

Neurizon Therapeutics's Revenue per Share for the six months ended in Dec. 2024 was €0.00.

Neurizon Therapeutics YoY Rev. per Sh. Growth Historical Data

The historical data trend for Neurizon Therapeutics's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurizon Therapeutics YoY Rev. per Sh. Growth Chart

Neurizon Therapeutics Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

-30.00

-42.86

75.00

-28.57

-100.00

Neurizon Therapeutics Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial															100.00	-75.00	-100.00	-100.00	-

Neurizon Therapeutics YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Neurizon Therapeutics's YoY Rev. per Sh. Growth for the fiscal year that ended in Jun. 2024 is calculated as:

	YoY Rev. per Sh. Growth (A: Jun. 2024 )
=	(Revenue per Share (A: Jun. 2024 )	-	Revenue per Share (A: Jun. 2023 ))	/	\| Revenue per Share (A: Jun. 2023 ) \|
=	(0	-	0.005)	/	\| 0.005 \|
=	-100.00 %

Neurizon Therapeutics's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2024 is calculated as:

	YoY Rev. per Sh. Growth (Q: Dec. 2024 )
=	(Revenue per Share (Q: Dec. 2024 )	-	Revenue per Share (Q: Dec. 2023 ))	/	\| Revenue per Share (Q: Dec. 2023 )) \|
=	(0	-	0)	/	\| 0 \|
=	N/A %

Neurizon Therapeutics YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Neurizon Therapeutics's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurizon Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurizon Therapeutics Ltd (FRA:ECQ0) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

Traded in Other Exchanges

NUZ:Australia

Address

96-100 Albert Road, Level 4, South Melbourne, Melbourne, VIC, AUS, 3205

Website

https://www.neurizon.com

Neurizon Therapeutics Ltd is a clinical-stage biotech company that develops drug discovery intellectual property for the treatment of different types of neurodegenerative diseases. Its product pipeline is NUZ-001 (S-Monepantel).

Neurizon Therapeutics Headlines

No Headlines